Three weeks after the Supreme Court’s decision to strike down federal abortion rights, the lab filed an application with the US Food and Drug Administration to market the first birth control pill.
How far will the Supreme Court of the United States stand? That’s the question millions of women in Uncle Sam’s country have been asking since the nation’s highest court struck down abortion rights in late June. And the statements of some judges are hardly encouraging. One of them, Clarence Thomas, mentioned the right to access contraceptives as a “future file”. Calendar Opportunity This Monday, July 11, Perrigo Laboratories, the French subsidiary of the pharmaceutical group HRA Pharma, announced that it has asked the US authorities to give the green light to what will be the first birth control pill available without a prescription. The United States.
“a turning point in contraceptive access”
“Time is a coincidence. We have been working on this request for the past seven years,” HRA Pharma’s director of strategic operations and innovation Frederic Welgreen said in a company press release. The pill in question, Opill, a synthetic progestogen-based and estrogen-free daily contraceptive, has been available by prescription since 1973.
With this “historic” procedure, Perrigo Labs hopes to mark “a turning point for contraceptive access and reproductive justice in the United States.” As Reuters news agency reports, nearly a third of adult American women say they have trouble getting a prescription or refill for birth control. However, “several studies have shown that women are able to use self-screening tools to determine their eligibility for hormonal contraceptives,” says pharmaceutical group HRA Pharma.
“I don’t care what the Bible says.” in the video, the heart cry of an American journalist about abortion.
Over-the-counter elsewhere in the world
This report will now be reviewed by the US Food and Drug Administration (FDA), and a decision may be made within a year, Reuters reports. If given the green light by health authorities, it will “help more women and people access contraception without facing unnecessary barriers”, summarizes Frederick Welgreen, director of strategic operations and innovation.
Over-the-counter birth control is supported by the nation’s major medical organizations, including the American Medical Association, the American Academy of Family Physicians, and the American College of Obstetricians and Gynecologists (ACOG). The latter assesses these progestogenic hormonal methods as “generally safe” and presents a “minimal risk of venous thromboembolism.”
Elsewhere in the world, the practice is common in many countries, including Brazil, Greece, Mexico, Portugal, Russia, South Korea and Turkey. On the French side, women also have to get an expensive prescription to use their contraceptive.
Source: Le Figaro
